Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer
For cosmetic manufacturers and formulators, choosing high-purity GHK-Cu (CAS 49557-75-7) is the key to developing high-quality skincare products
Their combined ability to inhibit tyrosinase has led to popularity as a skinbrightening duo, but the evidence supporting intravenous use in healthy people is limited, and the potential risks are significant
Additionally, taking it consistently at the same time each day can help maintain stable levels in the body
Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
For pharmacological interventions, treatment of mice was initiated once the average tumour volume in the groups reached approximately 300 mm 3